3//SEC Filing
JDRF T1D Fund LLC 3
Accession 0000899243-20-019442
CIK 0001807901other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 8:19 PM ET
Size
6.0 KB
Accession
0000899243-20-019442
Insider Transaction Report
Form 3
JDRF T1D Fund LLC
10% Owner
Holdings
Series B Preferred Stock
→ Common Stock (222,020 underlying)Series A Prime Preferred Stock
→ Common Stock (204,313 underlying)
Footnotes (2)
- [F1]The Series A Prime Preferred Stock is convertible into Common Stock on a 4.6410-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
- [F2]The Series B Preferred Stock is convertible into Common Stock on a 5.0994-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares have no expiration date.
Documents
Issuer
Pandion Therapeutics, Inc.
CIK 0001807901
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001817634
Filing Metadata
- Form type
- 3
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 8:19 PM ET
- Size
- 6.0 KB